valyl-glycyl-valyl-alanyl-prolyl-glycine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blood, CH; Zetter, BR | 1 |
| Blood, CH; Brodt, P; Sasse, J; Zetter, BR | 1 |
2 other study(ies) available for valyl-glycyl-valyl-alanyl-prolyl-glycine and Lung Neoplasms
| Article | Year |
|---|---|
Laminin regulates a tumor cell chemotaxis receptor through the laminin-binding integrin subunit alpha 6.
Topics: Animals; Antibodies; Binding, Competitive; Chemotaxis; Fibronectins; Integrins; Laminin; Lung Neoplasms; Mice; Oligopeptides; Protein Kinase C; Receptors, Cell Surface; Serum Albumin, Bovine; Tumor Cells, Cultured | 1993 |
Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide.
Topics: Animals; Chemotactic Factors; Cross-Linking Reagents; Elastin; Lung Neoplasms; Molecular Weight; Neoplasm Proteins; Oligopeptides; Receptors, Cell Surface; Tumor Cells, Cultured | 1988 |